Ayala Pharmaceuticals, Inc.
ADXSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001100397
Ayala Pharmaceuticals, Inc. was delisted in 2025; its insiders filed their last Form 4 on Mar 6, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Ayala Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Ayala Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Israel Biotech Fund I, L.P. | Director, 10% Owner | 25,130,903Indirect | Mar 6, 2024 | 0 |
| Israel Biotech Fund II, L.P. | Director, 10% Owner | 25,130,903Indirect | Mar 6, 2024 | 0 |
| I.B.F. Management Ltd. | Director, 10% Owner | 25,130,903Indirect | Mar 6, 2024 | 0 |
| Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | 25,130,903Indirect | Mar 6, 2024 | 0 |
| Israel Biotech Fund GP Partners II, L.P. | Director, 10% Owner | 25,130,903Indirect | Mar 6, 2024 | 0 |
| aMoon Growth Fund Limited Partnership | 10% Owner | 560,602 | Oct 23, 2023 | 0 |
| Goldberg Murray A | Director | – | Jan 23, 2023 | 0 |
| Sidransky David | Director | 46Indirect | Jan 23, 2023 | 0 |
| Spiegel Robert J. | Director | – | Jan 23, 2023 | 0 |
| Bisker-Leib Vered | Director | – | Jan 23, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 (view filing)9:04 AM ET | Nov 17 | 4 days | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchase | +43.8M | – | – | –27.6M after | Derivative10 lots |
| Oct 31, 2023 (view filing)7:08 AM ET | Oct 18 | 13 daysLate | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +1.32M | $0.00 | $0 | New position1.09M after | 2 lots |
| Sep 29, 2023 (view filing)6:13 AM ET | Sep 1 | 28 days | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchase | +1.74M | – | – | –434.8K after | AmendedDerivative2 lotsPrice outlierDuplicate filing |
| Sep 11, 2023 (view filing)12:44 PM ET | Sep 1 | 10 daysLate | Israel Biotech Fund I, L.P. and 1 other10% Owner | PPurchase | +1.74M | – | – | –434.8K after | Derivative2 lotsPrice outlier |